Form 4: Colgate-Palmolive Executive Sally Massey Exercises Stock Options and Sells Shares
SEC Form 4 Filing
Sally Massey, Chief Human Resources Officer at Colgate-Palmolive, exercised stock options and sold shares to cover the exercise price and related taxes.
Summary
- On May 9, 2024, Sally Massey, Chief Human Resources Officer of Colgate-Palmolive, exercised stock options for 12,226 shares of common stock at a price of $72.29 per share.
- Simultaneously, Massey sold 12,226 shares of common stock at a weighted average price of $94.0558 per share, with prices ranging from $94.05 to $94.0802.
- The sale of shares was intended to cover the exercise price of the options and related tax withholding.
- Following these transactions, Massey directly owns 13,924 shares of Colgate-Palmolive common stock and indirectly owns 7,744 shares through the Issuer's 401(k) Plan Trustee.
Sentiment
Score: 5
Explanation: The document is a neutral report of insider trading activity. It doesn't inherently convey positive or negative sentiment about the company's performance or prospects.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency into the trading activities of company executives. It's common for executives to exercise stock options and sell a portion of the acquired shares to cover the associated costs.
Comparison to Industry Standards
- Executive compensation packages often include stock options to align management's interests with those of shareholders.
- The exercise and sale of shares by Sally Massey is a typical practice among executives at publicly traded companies.
- Similar transactions are regularly reported by executives at companies like Procter & Gamble (PG) and Unilever (UL).
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders.
- It provides transparency to shareholders regarding executive compensation and trading activities.
Key Dates
| Date | Description |
|---|---|
| 09/12/2019 | Grant date of the stock options, which became exercisable in one-third increments beginning on the first anniversary. |
| 05/09/2024 | Date of the stock option exercise and share sale. |
| 05/10/2024 | Date of signature by Attorney-in-Fact. |
| 09/12/2027 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.